Cabergoline |
Dopamine receptor D1 (DRD1) |
Small molecule |
Neuroendocrine tumors, pituitary tumors |
1996 |
Lanreotide |
Somatostatin receptor (SSTR) |
Hormone |
Pancreatic cancer |
2007 |
Degarelix |
Gonadotropin releasing factor hormone receptor (GnRH) |
Hormone |
Prostate cancer |
2008 |
Plerixafor |
C-X-C chemokine receptor 4 (CXCR4) |
Small molecule |
Multiple myeloma |
2008 |
Vismodegib (Erivedge) |
Smoothened receptor (SMO) |
Small molecule |
Locally advanced, and metastatic basal cell carcinoma |
2012 |
Raloxifene |
Estrogen receptor (ER) |
Small molecule |
Breast cancer |
2014 |
Sonidegib (Odomzo) |
Smoothened receptor (SMO) |
Small molecule |
Locally advanced, and metastatic basal cell carcinoma |
2015 |
Mogamulizumab |
C–C Chemokine receptor 4 (CCR4) |
Antibody |
T cell
lymphoma |
2018 |